Anti-Angiogenic treatment of cervical cancer: Significant tumor regression with severe toxicity
Palavalli Parsons, L.H, Roane, B.M, Manders, D.B, Miller, D.S, Lea, J.S
Published in Gynecologic oncology (01.06.2016)
Published in Gynecologic oncology (01.06.2016)
Get full text
Journal Article
Predictive value of carcinoembryonic antigen and cancer antigen 125 in identifying mucinous ovarian tumors
Manders, D.B, Purinton, S.C, Lea, J.S, Richardson, D.L, Miller, D.S, Kehoe, S.M
Published in Gynecologic oncology (01.11.2011)
Published in Gynecologic oncology (01.11.2011)
Get full text
Journal Article
Outcomes of third line chemotherapy for recurrent and persistent cervical cancer
Manders, D.B, Purinton, S.C, Lea, J.S, Miller, D.S, Kehoe, S.M, Richardson, D.L
Published in Gynecologic oncology (01.11.2011)
Published in Gynecologic oncology (01.11.2011)
Get full text
Journal Article
Factors associated with clinical trial screening failures in gynecologic oncology
Paulsen, A, Richardson, D.L, Kehoe, S.M, Miller, D.S, Lea, J.S
Published in Gynecologic oncology (01.06.2014)
Published in Gynecologic oncology (01.06.2014)
Get full text
Journal Article